Skip to main content
. 2011 May 20;8(4):321–331. doi: 10.7150/ijms.8.321

Table 2.

Hepatitis B Marker Combinations in the Study Population (n=3833)

MODE Frequency Percent Cumulative Frequency Cumulative Percent
HBsAg (+) 13 0.34 13 0.34
HBsAg (+) and HBeAg (+) 1 0.03 14 0.37
HBsAg (+) and HBeAg (+) and Anti-HBc (+) 20 0.52 34 0.89
HBsAg (+) and Anti-HBe (+) and Anti-HBc (+) 69 1.80 103 2.69
HBsAg (+) and Anti-HBc (+) 45 1.17 148 3.86
Anti-HBs (+) 471 12.29 1169 30.50
Anti-HBc (+) 499 13.02 698 18.21
Anti-HBe (+) 35 0.91 3706 96.69
Anti-HBs (+) and Anti-HBc (+) 782 20.40 3660 95.49
Anti-HBs (+) and Anti-HBe (+) 11 0.29 3671 95.77
Anti-HBe (+) and Anti-HBc (+) 51 1.33 199 5.19
None 1709 44.59 2878 75.08
Other 127 3.31 3833 100.00

HBsAg, hepatitis B surface antigen; anti-HBs, antibody to hepatitis B surface antigen; HBeAg, hepatitis B e antigen; anti-HBe, antibody to HBeAg; anti-HBc, antibody to hepatitis B core antigen.